ADB-101

N/A

Report date: 2024/09/19 13:54:08

Base Information

Drug NameADB-101
Drug Alias NameADB-101ADB101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector
Mechanisms of ActionCarbonic anhydrase-related protein gene transference
TargetsCarbonic anhydrase-related protein
Therapy Area/IndicationsErythromelalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdolore Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsErythromelalgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A